RadNet Reports Second Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA(1) and Revises Upwards 2026 Financial Guidance Ranges

Impact · against what's priced in

RadNet is seeing significant catalysts from both its core imaging business and its AI-driven Digital Health segment. The upward revision of 2026 guidance and the nearly 100% year-over-year growth in AI recurring revenue provide a strong positive signal for valuation expansion.

RDNT+0.70

No priced-in read yet